Craft

Jafron Biomedical

Stock Price

¥32

2024-10-29

Market Capitalization

¥25.1 B

2024-10-29

Revenue

¥2 B

FY, 2025

Jafron Biomedical Summary

Company Summary

Overview
Jafron Biomedical (健帆生物科技集团股份有限公司) is a provider of medical devices and services for the hemoadsorption industry. Its products include HA series hemoperfusion cartridges, BS bilirubin adsorption and DNA immunoadsorption columns, blood purification machines, resin bandages, disinfectants, hemodialysis concentrates, and other products. The company also provides therapy services to patients, covering ESRD diseases, acute poisoning, critical illness, hepatopathy, immunological disorders, etc.
Type
Public
Status
Active
Founded
1989
HQ
Zhuhai, CN | view all locations
Website
https://www.jafroninternational.com
Cybersecurity rating
Sectors

Key People

  • Dong Fan

    Dong Fan, Founder, Chairman, President, and Chief Executive Officer

    • Tang Xianmin, Vice President

      • Wu Aijun, Vice President

        LocationsView all

        1 location detected

        • Zhuhai, Guang Dong Sheng HQ

          China

          No. 98 Technology Six Road, High-tech Zone

        Jafron Biomedical Financials

        Summary Financials

        Revenue (Q1, 2026)
        ¥549.6M
        Gross profit (Q1, 2026)
        ¥422.0M
        Net income (Q1, 2026)
        ¥220.6M
        Cash (Q1, 2026)
        ¥470.2M
        EBIT (Q1, 2026)
        ¥267.3M
        Enterprise value
        $25.9B

        Footer menu